meanwhile, so to speak, since Neuren has offered shares, in the most total indifference of the market, it has enlarged and obtained the patent 2591 in the rest of the world, in countries such as Denmark, Brazil and Eastern Europe.there is no doubt that even with this latest capital injection, Neuren is able to satisfy the full development of 2591 and even a global commercialization, therefore behind this project there is inevitably a much larger entity. this placement is private so it has a precise direction.in a few hours we will begin to discover some more elements of all this extraordinary activity put in place by the company in the last three months. my feeling is more and more adherent to a thick partnership with connection to a transfer of control.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)